Freeze-Drying and Lyopreservation of Diblock and Triblock Poly(Lactic Acid)–Poly(Ethylene Oxide) (PLA–PEO) Copolymer Nanoparticles

REFERENCES

• Stolnik S., Illum L., Davis S. S. Long circulating microparticulate drug carriers. Adv. Drug Deliv. Rev. 1995; 16: 195–214
   Web of Science ®Google Scholar
• Franks F. Freeze-drying of bioproducts: putting principles into practice. Eur. J. Pharm. Biopharm. 1998; 45: 221–229
   PubMed Web of Science ®Google Scholar
• Shah S. S., Zhu K. J., Pitt C. G. Poly-DL-lactic acid: polyethylene glycol block copolymers. J. Biomater. Sci., Polym. 1994; 5: 421–431, The influence of polyethylene glycol on the degradation of poly-DL-lactic acid
   PubMed Web of Science ®Google Scholar
• Youxin L., Volland C., Kissel T. In-vitro degradation and bovine serum albumin release of the ABA triblock copolymers consisting of poly(L(+)lactic acid), or poly(L(+)lactic acid-co-glycolic acid) A-blocks attached to central polyoxyethylene B-blocks. J. Controlled Release 1994; 32: 121–128
   Web of Science ®Google Scholar
• De Jaeghere F., Allémann E., Leroux J. C., Stevels W., Feijen J., Doelker E., Gurny R. Formulation and lyoprotection of poly(lactic acid-co-ethylene oxide) nanoparticles: influence on physical stability and in vitro cell uptake. Pharm. Res. 1999; 16: 859–865
   PubMed Web of Science ®Google Scholar
• Stevels W. M., Ankoné M. J. K., Dijkstra P. J., Feijen J. Stereocomplex formation in ABA triblock copolymers of poly(lactide) (A) and poly(ethylene glycol) (B). Macromol. Chem. Phys. 1995; 196: 3687–3694
   Web of Science ®Google Scholar
• Youxin L., Kissel T. Synthesis and properties of biodegradable ABA triblock copolymers consisting of poly(L-lactic acid) or poly(L-lactic-co-glycolic acid) A-blocks attached to central poly(oxyethylene) B-blocks. J. Controlled Release 1993; 27: 247–257
   Web of Science ®Google Scholar
• Leroux J. C., De Jaeghere F., Anner B. M., Doelker E., Gurny R. An investigation on the role of plasma and serum opsonins on the internalization of biodegradable poly(D,L-lactic acid) nanoparticles by human monocytes. Life Sci. 1995; 57: 695–703
   PubMed Web of Science ®Google Scholar
• Allémann E., Doelker E., Gurny R. Drug loaded poly(lactic acid) nanoparticles produced by a reversible salting-out process: purification of an injectable dosage form. Eur. J. Pharm. Biopharm. 1993; 39: 13–18
   Web of Science ®Google Scholar
• Nuysink J., Koopal L. K. The effect of polyethylene oxide molecular weight on determination on its concentration in aqueous solutions. Talanta 1982; 29: 495–501
   PubMed Web of Science ®Google Scholar
• Maste M. C. L., van Velthoven P. C. M., Norde W., Lyklema J. Synthesis and characterization of a short-haired poly(ethylene oxide)-grafted polystyrene latex. Colloids Surf. 1994; 83: 255–260
   Google Scholar
• Allémann E., Leroux J. C., Gurny R., Doelker E. In vitro sustained release properties of drug loaded poly (D,L-lactic acid) nanoparticles produced by a salting-out procedure. Pharm. Res. 1993; 10: 1732–1737
   PubMed Web of Science ®Google Scholar
• Zambaux M. F., Bonneaux F., Gref R., Dellacherie E., Vigneron C. MPEO–PLA nanoparticles: effect of MPEO content on some of their surface properties. J. Biomed. Mater. Res. 1999; 44: 109–115
   PubMed Web of Science ®Google Scholar
• Stolnik S., Dunn S. E., Garnett M. C., Davies M. C., Coombes A. G. A., Taylor D. C., Irving M. P., Purkiss S. C., Tadros T. F., Davis S. S., Illum L. Surface modification of poly(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)-poly(ethylene glycol) copolymers. Pharm. Res. 1994; 11: 1800–1808
   PubMed Web of Science ®Google Scholar
• Verrecchia T., Spenlehauer G., Bazile D. V. Non-stealth (poly(lactic acid/albumin)) and stealth (poly(lactic acid-polyethylene glycol)) nanoparticles as injectable drug carriers. J. Controlled Release 1995; 36: 49–61
   Web of Science ®Google Scholar
• Bazile D., Prud'Homme C., Bassoullet M. T., Marlard M., Spenlehauer G., Veillard M., Stealth M. PEG–PLA nanoparticles avoid uptake by the mononuclear phagocytes system. J. Pharm. Sci. 1995; 84: 493–498
   PubMed Web of Science ®Google Scholar
• Gref R., Minamitake Y., Peracchia M. T., Trubetskoy V. S., Torchilin V. P., Langer R. Biodegradable long circulating polymeric nanospheres. Science 1994; 263: 1600–1603
   PubMed Web of Science ®Google Scholar
• Peracchia M. T., Vauthier C., Puisieux F., Couvreur P. Development of sterically stabilized poly(isobutyl 2-cyanoacrylate) nanoparticles by chemical coupling of poly(ethylene glycol). J. Biomed. Mater. Res. 1997; 34: 317–326
   PubMed Web of Science ®Google Scholar
• Peracchia M. T., Gref R., Minamitake Y., Domb A., Lotan N., Langer R. PEG-coated nanospheres from amphiphilic diblock and multiblock copolymers: investigation of their drug encapsulation and release characteristics. J. Controlled Release 1997; 46: 223–231
   Web of Science ®Google Scholar
• Miller D. P., de Pablo J. J., Corti H. Thermophysical properties of trehalose and its concentrated aqueous solutions. Pharm. Res. 1997; 14: 578–590
   PubMed Web of Science ®Google Scholar
• Auvillain M., Cavé G., Fessi H., Devissaguet J. P. Lyophilisation de vecteurs colloidaux submicroniques. S.T.P. Pharma. 1998; 5: 738–744
   Google Scholar
• De Chasteigner S., Cavé G., Fessi H., Devissaguet J. P., Puisieux F. Freeze-drying of itraconazole-loaded nanospheres suspensions: a feasibility study. Drug Dev. Res. 1996; 38: 116–124
   Web of Science ®Google Scholar
• Carpenter J. F., Pikal M. J., Chang B. S., Randolph T. W. Rational design of stable lyophilized protein formulations: some practical advice. Pharm. Res. 1997; 14: 969–975
   PubMed Web of Science ®Google Scholar
• van Winden E. C. A., Zhang W., Crommelin D. J. A. Effect of freezing rate on the stability of liposomes during freeze-drying and rehydration. Pharm. Res. 1997; 14: 1151–1160
   PubMed Web of Science ®Google Scholar
• Tanaka K., Takeda T., Fujii K., Miyajima K. Cryoprotective mechanism of saccharides on freeze-drying of liposome. Chem. Pharm. Bull. 1992; 40: 1–5
   Web of Science ®Google Scholar
• Randolph T. W. Phase separation of excipients during lyophilization: effects on protein stability. J. Pharm. Sci. 1997; 86: 1198–1202
   PubMed Web of Science ®Google Scholar
• Izutsu K.-I., Yoshioka S., Kojima S., Randolph T. W., Carpenter J. F. Effects of sugar and polymers on crystallization of poly(ethylene glycol) in frozen solutions: phase separation between incompatible polymers. Pharm. Res. 1996; 13: 1393–1400
   PubMed Web of Science ®Google Scholar
• Franks F. Freeze drying: from empiricism to predictability. Cryo-Letters 1990; 11: 93–110
   Google Scholar
• Jiang S., Nail S. L. Effect of process conditions on recovery of protein activity after freezing and freeze-drying. Eur. J. Pharm. Biopharm. 1998; 45: 249–257
   PubMed Web of Science ®Google Scholar
• Chang B. S., Kendrick B. S., Carpenter J. F. Surface-induced denaturation of proteins during freezing and its inhibition by surfactants. J. Pharm. Sci. 1996; 12: 1325–1330
   Google Scholar
• Ma X., Santiago N., Chen Y. S., Chaudhary K., Milstein S. J., Baughman R. A. Stability study of drug-loaded proteinoid microsphere formulations during freeze-drying. J. Drug Targeting 1994; 2: 9–21
   PubMed Web of Science ®Google Scholar
• Hsu C. C., Nguyen H. M., Yeung D. A., Brooks D. A., Koe G. S., Bewley T. A., Pearlman R. Surface denaturation at solid-void interface—A possible pathway by which opalescent particulates form during the storage of lyophilized tissue-type plasminogen activator at high temperatures. Pharm. Res. 1995; 12: 69–77
   PubMed Web of Science ®Google Scholar